TOP NEWS By DAVID D. KIRKPATRICK and LIAM STACK After three days of increasingly violent demonstrations, Egypt's interim civilian government submitted its resignation to the country's ruling military council. By JENNIFER STEINHAUER and HELENE COOPER As the deficit committee met for what appeared to be the last time, Republican presidential candidates framed its failure as a lack of leadership by President Obama. By JAMES BARRON and JOSEPH GOLDSTEIN Jose Pimentel, accused of plotting to set off bombs in New York, praised Osama bin Laden on his blog and cited bomb-making articles from Al Qaeda's magazine. By ABBY ELLIN Beset by insurance costs and desperate to make ensure that drivers pass health tests, trucking companies and industry groups are working to persuade them to change their habits. By BRIAN STELTER The chancellor at the University of California, Davis, asks the district attorney to investigate campus police tactics after officers pepper sprayed seated protesters. |
Multimedia Steps toward liberalization in Myanmar lead to a planned United States visit; tens of thousands of Islamists protest Egypt's military; and this week in the 2012 Republican presidential race. Opinion Room for Debate The federal government requires applicants for certain civil service jobs to take a written exam. The same holds true for the foreign service. |
BUSINESS By CHRISTINE HAUSER and DAVID JOLLY Euro zone markets were also weighed down by a warning from Moody's that France would have to fight to retain its top rating. By GRETCHEN MORGENSON Maurice R. Greenberg, the former chief of A.I.G., contends that the takeover of the insurer in the fall of 2008 was improper and that the Fed breached its duty to A.I.G. shareholders. DealBook By MICHAEL J. DE LA MERCED and BEN PROTESS The court-appointed trustee overseeing the liquidation of MF Global's brokerage now estimates that the shortfall in the firm's customer funds could be more than $1.2 billion - double previous estimates. By KEITH BRADSHER Preparations to redesign supply chains, and then retaliate against U.S. exports, come after the U.S. Department of Commerce opened an anti-dumping and anti-subsidy case. DealBook By ANDREW POLLACK and MICHAEL J. DE LA MERCED Under the terms of the deal, Gilead Sciences will pay $137 a share in cash for Pharmasset, 89 percent above its closing share price on Friday. |
ليست هناك تعليقات:
إرسال تعليق